Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  Women's HealthIssue 730

Liver Enzymes Can Predict Gestational Diabetes Risk

Women with high levels of the liver enzyme gamma-glutamyl transferase before pregnancy may be more likely to develop gestational diabetes than those with lower levels.... 

Advertisement

Sneha B. Sridhar, MPH, of the division of research at Kaiser Permanente Northern California in Oakland, and colleagues compared medical records of 256 women who developed gestational diabetes with 497 women who did not develop gestational diabetes.

Sridhar said in a press release, "A few studies have looked at liver enzyme levels during pregnancy and the risk of gestational diabetes." "But, to our knowledge, this is the first to look at liver enzyme levels measured before pregnancy."

All of the women had participated in the Kaiser Permanente Northern California multiphasic health checkup (1984-1996) and had a subsequent pregnancy (1984-2009). Control participants were selected and matched based on year of blood draw (±3 months), age at examination (±2 years), number of intervening pregnancies (0, 1, ≥2) and age at delivery of index pregnancy (±2 years).

The highest quartile vs. the lowest quartile of gamma-glutamyl transferase (GGT) was associated with a twofold increased risk for subsequent gestational diabetes (OR=1.97; 95% CI, 1.14-3.42), after adjusting for race/ethnicity, pre-pregnancy BMI, family history of diabetes and alcohol use. When adjusted for homeostasis model assessment of insulin resistance (HOMA-IR), fasting status and rate of gestational weight gain, the results were diminished.

"The association appeared to be moderated by increased insulin resistance, and in the stratified analysis, it was present only among women who were in the top tertile of HOMA-IR before pregnancy," the researchers wrote.

No associations were found with two other commonly monitored liver enzymes, alanine aminotransferase and aspartate aminotransferase.

The researchers suggest a risk model to monitor GGT levels before pregnancy could identify women who might benefit from interventions even before conceiving.

Practice Pearls:
  • Consider monitoring GGT levels before pregnancy
  • No associations were found with two other commonly monitored liver enzymes, alanine aminotransferase

Sridhar SB. Diabetes Care. 2014;doi:10.2337/dc13-2229. 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 23 May, 2014 and appeared in  Women's HealthIssue 730

Past five issues: Issue 796 | Diabetes Clinical Mastery Series Issue 255 | Issue 795 | SGLT-2 Inhibitors Special Edition August 2015 | Diabetes Clinical Mastery Series Issue 254 |

2015 Most Popular Articles:

Coffee Consumption Proves Potential in Reducing Type 2 Diabetes Risk
Posted August 07, 2015
Impaired Glucose Uptake in the Brain May Increase Alzheimer's Disease Risk
Posted August 07, 2015
First Non-Surgical Weight Loss Procedure for Mild-to-Moderate Obesity
Posted August 07, 2015
GLP-1 Agonist Semaglutide Completes Phase III Trial with Positive Results
Posted August 07, 2015
Impact of Switching Insulin Glargine to Insulin Detemir in T2 Patients
Posted August 14, 2015
Ketoacidosis Not as Great as Thought in Diabetes Patients Taking Invokana
Posted August 13, 2015
Two New Possible Methods for Diagnosing and Monitoring Diabetes
Posted August 07, 2015
SIgnificant Weight Gain Associated with Laparoscopic Sleeve Gastrectomy
Posted August 14, 2015
Diabetes Combination Drug LixiLan Meets Main Target in Late Stage Trial
Posted August 07, 2015
A Telltale Sign of Type 2 Diabetes
Posted August 07, 2015


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
What percentage of your patients have reached goal for A1c, BP and cholesterol?

CME/CE of the Week
Marie Williams, DPM

Category: Wound Care
Credits: .75